Yucui C. Dong
Yantai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
ASVBM: Structural variant benchmarking with local joint analysis for multiple callsets.
Journal: Computational and structural biotechnology journal
Published: March 13, 2025
Paris saponin VII restrains PD-L1 mediated immune evasion through the AKT1 and STAT3 signaling pathways.
Journal: Chemico-biological interactions
Published: September 15, 2024
Corrigendum: 5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells.
Journal: Frontiers in oncology
Published: September 11, 2024
Prediction of acute myeloid leukemia prognosis based on autophagy features and characterization of its immune microenvironment.
Journal: Frontiers in immunology
Published: August 31, 2024
Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy.
Journal: Frontiers in immunology
Published: July 25, 2024
The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment.
The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment.
Journal: Medical oncology (Northwood, London, England)
Published: February 08, 2024
IGFBP3 induces PD-L1 expression to promote glioblastoma immune evasion.
Journal: Cancer cell international
Published: November 18, 2023
A comparative analysis of TCR immune repertoire in COVID-19 patients.
Journal: Human immunology
Published: July 26, 2023
5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells.
Journal: Frontiers in oncology
Published: January 13, 2023
The immunosuppressive microenvironment and immunotherapy in human glioblastoma.
Journal: Frontiers in immunology
Published: July 26, 2022
Last Updated: 09/26/2026